ESR1 and breast cancer: A functional drug screen using co-culture of breast cancer cells and CAFs revealed molecular signaling pathways contributing to the regulation of ER-α-signaling by CAFs, suggesting TGF-β and JAK signaling as potential nodes for intervention to counteract the paracrine regulation.